Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Vaccinations01:51

Vaccinations

44.3K
Overview
44.3K
Drug Dosing: Geriatric Patients01:15

Drug Dosing: Geriatric Patients

402
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
402
Pharmacodynamics in Geriatric Patients: Effects of Age01:27

Pharmacodynamics in Geriatric Patients: Effects of Age

378
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
378
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

358
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
358
Vaccines01:21

Vaccines

105
Vaccines are among the most effective tools in preventive medicine, designed to prepare the immune system to recognize and combat infectious agents. By introducing antigens—substances that the immune system identifies as foreign—vaccines stimulate an adaptive immune response that leads to immunological memory. This immunological memory enables the body to mount a faster and more effective response upon future exposures to the actual pathogen.Vaccines can be categorized based on the...
105
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism

406
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...
406

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Zeitschrift fur Gerontologie und Geriatrie·2026
Same author

[40th anniversary of the German Society of Geriatrics (DGG)-In demand, matured, strengthened : History of the DGG concerning scientific and professional political aspects].

Zeitschrift fur Gerontologie und Geriatrie·2025
Same author

Costs and resource utilization patterns in surgical site infections: a pre-COVID-19 perspective from France, Germany, Spain, and the UK.

The Journal of hospital infection·2024
Same author

Reply to letter to editor by Yin et al.

Vaccine·2024
Same author

[After the COVID-19 pandemic-Which new vaccinations for adults are available or coming soon?]

Innere Medizin (Heidelberg, Germany)·2023
Same author

Incidence, associated disease burden and healthcare utilization due to Staphylococcus aureus prosthetic joint infection in European hospitals: the COMBACTE-NET ARTHR-IS multi-centre study.

The Journal of hospital infection·2023
Same journal

[Journal Club].

Zeitschrift fur Gerontologie und Geriatrie·2026
Same journal

Effect of anticholinergic burden on cardiac functions in older patients.

Zeitschrift fur Gerontologie und Geriatrie·2026
Same journal

[Communication in later life under institutional conditions : Professional perspectives on communication of ageing people with profound intellectual and multiple disabilities].

Zeitschrift fur Gerontologie und Geriatrie·2026
Same journal

Zeitschrift fur Gerontologie und Geriatrie·2026
Same journal

Zeitschrift fur Gerontologie und Geriatrie·2026
Same journal

Zeitschrift fur Gerontologie und Geriatrie·2026
See all related articles

Related Experiment Video

Updated: May 6, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

2.2K

[Vaccination in the elderly].

A Kwetkat1, M W Pletz

  • 1Klinik für Geriatrie, Universitätsklinikum Jena, Bachstr. 18, 07743, Jena, Deutschland, anja.kwetkat@med.uni-jena.de.

Zeitschrift Fur Gerontologie Und Geriatrie
|October 16, 2013
PubMed
Summary
This summary is machine-generated.

Vaccinations are crucial for the elderly to combat increased infection risks due to immunosenescence. Recommended vaccines, including influenza and pneumococcal, can reduce disease severity and mortality in older adults.

More Related Videos

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

9.8K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.9K

Related Experiment Videos

Last Updated: May 6, 2026

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen
07:44

Fabrication of Pulsatile Polymeric Microparticles Encapsulating Rabies Antigen

Published on: May 12, 2023

2.2K
Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice
08:52

Evaluation of Host-Pathogen Responses and Vaccine Efficacy in Mice

Published on: February 22, 2019

9.8K
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

3.9K

Area of Science:

  • Immunology
  • Geriatrics
  • Public Health

Background:

  • The aging immune system, or immunosenescence, increases infection susceptibility and severity in the elderly.
  • Immunosenescence also reduces vaccine efficacy in older populations.
  • Infectious diseases pose significant morbidity and mortality risks for the elderly.

Purpose of the Study:

  • To highlight the importance of vaccination in mitigating infectious disease burden in the elderly.
  • To outline current vaccination recommendations for individuals aged 60 and above.
  • To discuss the potential benefits of enhanced immunogenicity in vaccines for older adults.

Main Methods:

  • Review of existing literature on immunosenescence and vaccination in the elderly.
  • Analysis of recommendations from the Standing Committee on Vaccination (STIKO).
  • Discussion of specific vaccine types and their administration schedules.

Main Results:

  • STIKO recommends annual influenza, one-time pneumococcal polysaccharide, and completion of tetanus and diphtheria (Td) vaccinations for those 60+.
  • All adults should receive a one-time tetanus, diphtheria, and acellular pertussis (Tdap) vaccine.
  • Pneumococcal conjugate vaccines are available but not yet STIKO-recommended for adults.

Conclusions:

  • Implementing STIKO vaccination guidelines can significantly reduce infectious disease impact in the elderly.
  • Lifelong vaccination strategies may help to counteract the effects of immunosenescence.
  • More immunogenic vaccines could offer enhanced protection for the aging population.